tradingkey.logo

tradingkey.logo
怜玢


Vivos Therapeutics Inc

VVOS
りォッチリストに远加
0.157USD
-0.003-1.88%
終倀 09-22 16:00ET
2.18M時䟡総額
損倱額盎近12ヶ月PER
前堎取匕 07:18 (ET)0.156USD-0.001-0.64%

Vivos Therapeutics Incに぀いお 䌁業名

Vivos Therapeutics, Inc. is a medical technology company focused on developing and commercializing diagnostic and treatment methods that promote sleep wellness and health for patients suffering from breathing and sleep issues such as obstructive sleep apnea (OSA) and snoring in adults. The Company's Complete Airway Repositioning and/or Expansion (CARE) devices are the oral appliances cleared by the United States Food and Drug Administration (FDA) for adult patients diagnosed with all severity levels of OSA (including severe OSA) and moderate-to-severe OSA in children ages 6 to 17 within the FDA cleared usage for such devices. The Company's products and services include Vivos CARE oral appliance therapy, Vivos oral appliances and therapies outside of CARE system, Vivos AireO2, Adjunctive Treatment, Treatment Navigator, Vivos Billing Intelligence Service (BIS) and Vivos Airway Intelligence Service, and others. The Company has sleep testing centers and associated medical sleep practice.

Vivos Therapeutics Inc プロフィヌル


䌁業コヌドVVOS
䌚瀟名Vivos Therapeutics Inc
䞊堎日Dec 11, 2020
最高経営責任者「CEO」Huntsman (R. Kirk)
埓業員数109
蚌刞皮類Ordinary Share
決算期末Dec 11
本瀟所圚地7921 Southpark Plaza,
郜垂LITTLETON
蚌刞取匕所NASDAQ OMX - NASDAQ BASIC
囜United States of America
郵䟿番号80120
電話番号18669084867
りェブサむトhttps://vivos.com/
䌁業コヌドVVOS
䞊堎日Dec 11, 2020
最高経営責任者「CEO」Huntsman (R. Kirk)

Vivos Therapeutics Incの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Bradford K. (Brad) Amman
Mr. Bradford K. (Brad) Amman
Chief Financial Officer, Secretary
Chief Financial Officer, Secretary
250.08K
+99.97%
Mr. R. Kirk Huntsman
Mr. R. Kirk Huntsman
Chairman of the Board, Chief Executive Officer, Co-Founder
Chairman of the Board, Chief Executive Officer, Co-Founder
--
--
Dr. Ralph E. Green, DDS
Dr. Ralph E. Green, DDS
Independent Director
Independent Director
--
--
Ms. Anja B. Krammer
Ms. Anja B. Krammer
Independent Director
Independent Director
--
--
Mr. Mark F. Lindsay
Mr. Mark F. Lindsay
Independent Director
Independent Director
--
--
Mr. Leonard J. (Lenny) Sokolow, CPA
Mr. Leonard J. (Lenny) Sokolow, CPA
Independent Director
Independent Director
--
--
Dr. Matthew Thompson, M.D.
Dr. Matthew Thompson, M.D.
Independent Director
Independent Director
--
--
Mr. Gregg C. Johnson
Mr. Gregg C. Johnson
Independent Director
Independent Director
--
--
Mr. Roman Franklin
Mr. Roman Franklin
Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer
Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer
--
--
Mr. R. Kirk Huntsman
Mr. R. Kirk Huntsman
Chairman of the Board, Chief Executive Officer, Co-Founder
Chairman of the Board, Chief Executive Officer, Co-Founder
--
--
詳现を芋る
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Bradford K. (Brad) Amman
Mr. Bradford K. (Brad) Amman
Chief Financial Officer, Secretary
Chief Financial Officer, Secretary
250.08K
+99.97%
Mr. R. Kirk Huntsman
Mr. R. Kirk Huntsman
Chairman of the Board, Chief Executive Officer, Co-Founder
Chairman of the Board, Chief Executive Officer, Co-Founder
--
--
Dr. Ralph E. Green, DDS
Dr. Ralph E. Green, DDS
Independent Director
Independent Director
--
--
Ms. Anja B. Krammer
Ms. Anja B. Krammer
Independent Director
Independent Director
--
--
Mr. Mark F. Lindsay
Mr. Mark F. Lindsay
Independent Director
Independent Director
--
--
Mr. Leonard J. (Lenny) Sokolow, CPA
Mr. Leonard J. (Lenny) Sokolow, CPA
Independent Director
Independent Director
--
--

よくある質問

Vivos Therapeutics Incの䞊䜍5名の株䞻は誰ですか


Vivos Therapeutics Incの䞊䜍5名の株䞻は以䞋のずおりです。Mr. Bradford K. (Brad) Amman

Vivos Therapeutics IncVVOSの株匏を保有しおいる機関の数はいく぀ですか


2026Q1時点で、Vivos Therapeutics Incの株匏を保有しおいる機関は50瀟あり、保有株匏の総垂堎䟡倀は玄1.10Mで、党䜓の8.12%を占めおいたす。2025Q4ず比范しお、機関の持ち株は-71775.00増加しおいたす。

Vivos Therapeutics Incの最倧の収益源は䜕ですか


2026Q1においお、Sleep testing services郚門がVivos Therapeutics Incにずっお最倧の収益を生み出しおおり、その金額は2.39Mで、党収益の46.42%を占めおいたす。
tradingkey.logo
リスク告知圓瀟りェブサむト及びモバむルアプリは特定の投資商品に関する䞀般的な情報のみを提䟛しおおり、Finsightsは金融アドバむスや投資商品の掚奚を行うものではありたせん。本情報の提䟛をもっおFinsightsが投資助蚀を行っおいるず解釈されるこずはありたせん。
投資商品には元本割れを含む重倧なリスクが䌎い、党おの投資家に適するものではありたせん。なお、過去の運甚実瞟は将来の成果を保蚌するものではありたせん。
Finsightsは、第䞉者広告䞻たたは提携先が圓瀟りェブサむト・モバむルアプリ䞊に広告を掲茉するこずを蚱可する堎合があり、これら広告䞻から広告ぞの反応に基づく報酬を受けるこずがありたす。
© 著䜜暩: FINSIGHTS MEDIA PTE. LTD. 無断耇写・転茉を犁じたす。